Daiichi Sankyo Co Ltd
TSE:4568
Daiichi Sankyo Co Ltd
TSE:4568
Price:
5 486 JPY
1.31%
Market Closed
Updated:
May 15, 2024
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT
50.1
Current
60.9
Median
17.5
Industry
Lower
than median
Higher
than industry value
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
EV/EBIT
=50.1
Enterprise Value
/
9.4T
EBIT
188B
All Countries
| Market Cap | EV/EBIT | ||||
|---|---|---|---|---|---|
| JP |
|
Daiichi Sankyo Co Ltd
TSE:4568
|
10.5T JPY | 50.1 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | -5 046 864.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
737.3B USD | 66.9 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
4.1T DKK | 37.5 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 17 702.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
364.3B USD | 15.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
329.3B USD | 58.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
189.6B GBP | 278.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
182.6B CHF | 12.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
181.5B CHF | 10.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161.6B USD | 20.6 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBIT
0.4
2-Years Forward
EV/EBIT
0.4
3-Years Forward
EV/EBIT
0.3
You don't have any saved screeners yet
